
Olin (OLN) is drawing attention after publishing full-year figures that combine revenue of $6,780.8 million, a net income loss of $100.5 million, and annual revenue and net income growth rates of 2.24% and 83.97%, respectively.
See our latest analysis for Olin.
The full year update comes as Olin’s share price has moved sharply in the short term, with a 9.42% 1 day share price return and a 20.70% year to date share price return, while there has been a 46.26% decline in 3 year total shareholder return. This may signal shifting sentiment around both near term prospects and longer term risk.
If Olin’s recent move has you thinking about where else value or momentum might be building, this could be a good moment to scan 8 top copper producer stocks for other materials names on your radar.
With Olin trading at US$26.01 against an analyst price target of US$22.60, but showing a 63% intrinsic discount and a mixed return record, is there real value on the table here, or is the market already pricing in future growth?
The most followed narrative puts Olin’s fair value at $22.07, which sits below the latest close of $26.01 and frames the current optimism as relatively full.
Structural cost reduction initiatives (Beyond250 and Epoxy cost optimization) are expected to deliver significant operational savings, yielding an estimated $70 to $90 million run-rate benefit by the end of 2025 and additional structural cost reductions from the Stade, Germany facility in 2026; this should improve net margins and boost earnings quality.
If you want to see what is really doing the heavy lifting behind that fair value, look at how revenue, margins and future earnings power are wired into this story.
Result: Fair Value of $22.07 (OVERVALUED)
Have a read of the narrative in full and understand what's behind the forecasts.
However, pressure from global oversupply in key chemicals and margin strain in Winchester ammunition could still disrupt earnings and challenge the current valuation story.
Find out about the key risks to this Olin narrative.
So far, the focus has been on a fair value of $22.07 that frames Olin as 17.9% overvalued. Yet on a P/S of 0.4x, the stock sits well below the US Chemicals industry at 1x, peers at 1.2x, and even a 0.7x fair ratio that the market could move toward.
That spread suggests the shares are priced more like a low conviction name than one trading above its worth. This raises a simple question for you as an investor: is the earnings narrative right, or is sentiment leaning too hard on the risks baked into today’s price?
See what the numbers say about this price — find out in our valuation breakdown.
Mixed messages in the story so far? Take a moment to look through the full picture yourself and move quickly to form your own stance with 3 key rewards and 2 important warning signs
If Olin has sharpened your focus, do not stop here. Use the Simply Wall Street Screener to quickly spot other opportunities that match your style.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com